2024 ASCO® Annual Meeting Insights Hub

Meeting coverage & Vumedi’s exclusive highlights, all in one place.

 

ecancer
R

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxel in Patients With Previously Treated Advanced/Metastatic NSCLC Harboring a KRASG12C Mutation"

By ecancer FEATURING Robert Jotte
By ecancer FEATURING Robert Jotte
161 views
June 21, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

19:30
AstraZeneca Oncology

The Importance of HRD Testing in Advanced Ovarian Cancer

Feat. M. Markman

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
Lung
17:22
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "SCLC Treatment Evolution - Debunking Myths…

Feat. A. Chiang
40:00
ecancer

ASCO® 2024: Highlights and Analysis of Key Solid Cancer Trials

Feat. B. Gyawali
04:26
ecancer

ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance vs. Local C…

Feat. P. Iyengar
05:26
ecancer

ASCO® 2024 Lung Cancer Updates: CROWN, ADRIATIC, and LAURA Trials

Feat. L. Raez
03:04
ecancer

ASCO® 2024 Insights: "HARMONi-A Study - Ivonescimab + Chemo for…

Feat. L. Zhang
19:33
ecancer

ASCO® 2024 Lung Cancer Roundtable: Advances in NSCLC

Feat. E. Felip, A. Spira, A. Passaro, A. Addeo
16:10
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOM…

Feat. L. Raez
36:14
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

Feat. B. Halmos
11:45
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxe…

Feat. T. Mok
07:06
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "RAGNAR Trial - Erdafitinib Efficacy &…

Feat. M. Schuler
05:13
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "SAVE Study - Comparing Suspension vs. Con…

Feat. Y. Goto
12:10
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "BEAT Trials and Neoadjuvant Strategies - A…

Feat. M. Marmarelis
16:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

Feat. V. Subbiah
04:33
ecancer

ASCO® 2024 Insights: "ADRIATIC Study - Durvalumab as Consolidat…

Feat. D. Spigel
12:19
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "TROPION-Lung05 Study - Intracranial Effic…

Feat. A. Lisberg
02:57
ecancer

ASCO® 2024 Insights: "LAURA Study - Osimertinib After Definitiv…

Feat. S. Ramalingam
04:52
ecancer

ASCO® 2024 Insights: "Telehealth Palliative Care for Advanced L…

Feat. J. Greer
09:42
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "HARMONi-A Trial - Ivonescimab Combined Wi…

Feat. L. Zhang
11:28
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "ETOP 13-18 BEAT-meso Trial - Bevacizumab …

Feat. S. Popat
12:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "LIBRETTO-432 Trial - Adjuvant Selpercatin…

Feat. J. Goldman
02:26
ecancer

ASCO® 2024 Insights: "KRYSTAL-12 Study - Adagrasib vs. Docetaxe…

Feat. R. Jotte
08:25
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "CHRYSALIS-2 Trial - Amivantamab + Lazerti…

Feat. B. Chul Cho
09:34
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Assessing Secular Trends in Lung Cancer S…

Feat. J. Paulus
16:46
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NRG-LU002 Trial - Maintenance Systemic Th…

Feat. P. Iyengar
06:53
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Impact on Biomarker Documentation in Comm…

Feat. D. Rubin
09:01
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Evolution Trial - RT-Free Pembro + Chemo …

Feat. A. Hata
08:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "MIST5 Trial - Niraparib & Dostarlimab…

Feat. D. Fennell
05:44
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Multi-Center Phase II Trial Investigating…

Feat. S. Rashdan
07:40
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PALOMA-2 Study - Subcutaneous Amivantamab…

Feat. S. Min Lim
08:24
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "First-in-Human Trial of RSO-021 in Malign…

Feat. D. Fennell